White Paper

Optimizing Rare Disease Outcomes Through eCOA Technology And Training

Source: ERT

By Susan M. Dallabrida, Ph.D.

Optimizing Rare Disease Outcomes Through eCOA Technology And Training

The successful development of new rare disease treatments doesn’t have to be rare. Clinical trial sponsors who incorporate effective data capture strategies to optimize outcome measurement reduce clinical data risks, improve data quality and strengthen their risk management initiatives through near real-time data access ─ all of which produces a more accurate picture of treatment benefit and keeps development plans on track and on budget.

Read how utilizing electronic data capture systems ─ including eCOA ─ and training site raters, subjects and caregivers are important tools to ensure high quality data capture in rare disease research.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: